Press release —
Sana Alajmovic to leave as CEO of Sigrid Therapeutics in early 2026
Stockholm, August 12, 2025 – Sigrid Therapeutics AB (Sigrid) announces that CEO Sana Alajmovic will leave her operational role on January 31, 2026 to take up a new position outside of Sigrid's operations and that does not compete with the company.
Sana's decision comes during a period of strong growth for Sigrid, following the launch of Glucose Stabiliser, the completion of SHINE – one of the world's largest clinical studies in prediabetes – and intensified partnership discussions ahead of an international launch.
– Through her visionary leadership and hard work, Sana has laid the foundation for Sigrid's next phase of growth. The board is grateful for her efforts and wishes her every success in the next chapter, says Mattias Ankarberg, Chairman of the Board of Sigrid.
Sigrid Therapeutics was founded in 2014 based on Professor Tore Bengtsson's research in metabolic health. Tore, currently Chief Scientific Officer and Board Member, remains in his roles and continues to lead research and product development.
– Leading Sigrid from a research idea to a company with patented technology, clinical evidence and commercial products has been a fantastic journey. I am incredibly proud of the dedicated team that is driving Sigrid forward , says Sana Alajmovic.
The board is now beginning the process of recruiting a new CEO.
Topics
Categories
SIGRID is a Swedish consumer health company developing technologies designed to reduce the metabolic impact of modern meals. The company’s patented SiPore® technology works locally in the gastrointestinal tract by interacting with digestive enzymes involved in carbohydrate and fat digestion. By slowing nutrient breakdown during digestion, SiPore® supports steadier post-meal metabolic responses. SIGRID collaborates with clinicians, researchers, and health innovators to translate metabolic science into practical solutions supporting metabolic health, weight management, and glucose stability. The company was founded in 2014 and is headquartered in Stockholm, Sweden.
